Original Article

Prospective, Randomized, Double-blind, Contralateral Eye Comparison of Myopic LASIK With Optimized Aspheric or Prolate Ablations

Arturo Chayet, MD; Harkaran S. Bains

  • Journal of Refractive Surgery
  • February 2012 - Volume 28 · Issue 2: 112-119
  • DOI: 10.3928/1081597X-20111219-01
Rights and Permissions

Abstract

PURPOSE:

To compare the postoperative outcomes of aspheric or prolate LASIK for myopia and myopic astigmatism.

METHODS:

In this double-blind, bilateral, randomized trial, 40 patients (80 eyes) with −0.75 to −7.00 diopters (D) of manifest refraction spherical equivalent (MRSE) underwent optimized aspheric treatment zone ablation (OATz group) in 1 eye and optimized prolate ablation (OPA group) in the fellow eye. Six-month postoperative outcomes were compared for MRSE and visual acuity, contrast sensitivity, patient satisfaction, ocular higher order aberrations (HOAs), and spherical aberration. The Wilcoxon signed rank test, Mann-Whitney U test, and paired t test were used for testing differences between groups. P<.05 was statistically significant. Main outcome measures included HOAs, spherical aberration, visual and refractive outcomes, and contrast sensitivity.

RESULTS:

Postoperatively, 36 patients (72 eyes) were evaluated. The MRSE was −0.07±0.23 D for the OPA group and +0.02±0.24 D for the OATz group (P>.05). Two (5%) eyes in the OPA group and 1 (3%) eye in the OATz group (P=.114) lost 1 line of corrected distance visual acuity. Postoperative visual acuity was not statistically different between groups (P>.05). Statistically lower change was noted in spherical aberration (0.011 μm) in the OPA group versus the OATz group (0.099 μm) (P<.001). Statistically higher induction of coma was noted in the OPA group (P=.035). No statistically significant differences were noted in photopic, mesopic, or glare contrast sensitivity and patient satisfaction between groups (P>.05, for all comparisons).

CONCLUSIONS:

The refractive and visual outcomes of OPA and OATz were equivalent. However, the postoperative optical quality of OPA-treated eyes was better.

AUTHORS

From CODET Vision Institute, Tijuana, Mexico (Chayet); and Edmonton, Canada (Bains).

Both authors are members of the NIDEK Co Ltd Medical Advisory Board.

The authors have no financial or proprietary interests in the materials presented herein.

Correspondence: Harkaran S. Bains, 17927-80 Ave, Edmonton, AB, Canada T5T 0S6. E-mail: hsbains@ymail.com

Received: November 30, 2010
Accepted: November 01, 2011
Posted Online: December 29, 2011

doi: 10.3928/1081597X-20111219-01

Healio is intended for health care provider use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will Healio be used for medical advice to patients.

[X]